EDGAR Filing Documents for 0001193125-18-021593

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-18-021593

Filing Date

2018-01-26

Accepted

2018-01-26 16:08:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d507671ds3.htm	S-3	285090
2	EX-4.1	d507671dex41.htm	EX-4.1	321086
3	EX-4.2	d507671dex42.htm	EX-4.2	315203
4	EX-4.3	d507671dex43.htm	EX-4.3	38478
5	EX-4.4	d507671dex44.htm	EX-4.4	38417
6	EX-5.1	d507671dex51.htm	EX-5.1	25929
7	EX-12.1	d507671dex121.htm	EX-12.1	23011
8	EX-23.1	d507671dex231.htm	EX-23.1	1609
9	GRAPHIC	g507671g1214073117526.jpg	GRAPHIC	5105
10	GRAPHIC	g507671snap0001.jpg	GRAPHIC	2096
11	GRAPHIC	g507671snap0002.jpg	GRAPHIC	7714
	Complete submission text file	0001193125-18-021593.txt		1070809

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459

Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)